Sabra Health Care REIT - SBRA Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings or view top-rated stocks.

10 equities research analysts have issued 1 year target prices for Sabra Health Care REIT's shares. Their SBRA share price forecasts range from $10.50 to $15.50. On average, they expect the company's stock price to reach $13.78 in the next twelve months. This suggests a possible upside of 21.9% from the stock's current price.
View analysts price targets for SBRA or view top-rated stocks among Wall Street analysts.

Sabra Health Care REIT's stock was trading at $12.43 at the beginning of the year. Since then, SBRA stock has decreased by 9.1% and is now trading at $11.30.
View the best growth stocks for 2023 here.

Sabra Health Care REIT saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 14,010,000 shares, an increase of 30.2% from the February 28th total of 10,760,000 shares. Based on an average daily volume of 1,900,000 shares, the short-interest ratio is presently 7.4 days.
View Sabra Health Care REIT's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our SBRA earnings forecast.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) posted its earnings results on Wednesday, May, 4th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative trailing twelve-month return on equity of 2.40% and a negative net margin of 12.42%. During the same quarter last year, the company posted $0.39 earnings per share.

Sabra Health Care REIT announced a quarterly dividend on Wednesday, February 1st. Stockholders of record on Monday, February 13th will be given a dividend of $0.30 per share on Tuesday, February 28th. This represents a $1.20 annualized dividend and a yield of 10.62%. The ex-dividend date of this dividend is Friday, February 10th.
Read our dividend analysis for SBRA.

ETFs with the largest weight of Sabra Health Care REIT (NASDAQ:SBRA) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), ALPS REIT Dividend Dogs ETF (RDOG), ALPS Active REIT ETF (REIT), Hoya Capital High Dividend Yield ETF (RIET), Cambria Global Real Estate ETF (BLDG), Global X SuperDividend ETF (SDIV), iShares Residential and Multisector Real Estate ETF (REZ) and Invesco S&P MidCap Value with Momentum ETF (XMVM).

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 11.22%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Sabra Health Care REIT's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Principal Financial Group Inc. (6.73%), Deutsche Bank AG (4.92%), Centersquare Investment Management LLC (3.16%), Geode Capital Management LLC (2.15%), LSV Asset Management (2.00%) and Charles Schwab Investment Management Inc. (1.69%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews and Michael J Foster.
View institutional ownership trends.

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SBRA stock can currently be purchased for approximately $11.30.

Sabra Health Care REIT (NASDAQ:SBRA) has a market capitalization of $2.61 billion and generates $624.81 million in revenue each year. The real estate investment trust earns $-77,610,000.00 in net income (profit) each year or ($0.34) on an earnings per share basis.

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The official website for the company is www.sabrahealth.com. The real estate investment trust can be reached via phone at (888) 393-8248, via email at investorrelations@sabrahealth.com, or via fax at 949-679-8868.